SCHEMBL14201611

SCHEMBL14201611

CCCCCOCCOS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 1/20 0.45
ALDH1A1 P00352 5/20 0.44
MCHR1 Q99705 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA9 Q16790 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
CYP2C9 P11712 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
TSHR P16473 4/20 0.39
RECQL P46063 2/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
EPHX2 P34913 1/20 0.39
BLM P54132 1/20 0.39
LMNA P02545 1/20 0.38
ALB P02768 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23611505 1.00 PLA2G2C (0.45) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL6652024 0.98 PLA2G2C (0.47) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL2711886 0.98 PLA2G2C (0.47) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL5479556 0.98 PLA2G2C (0.47) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL17309273 0.98 PLA2G2C (0.47) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL12895049 0.95 CA12 (0.46) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL1276066 0.95 CA12 (0.46) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL20129020 0.95 PLA2G2C (0.46) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL21239937 0.95 CA12 (0.46) PLA2G2CALDH1A1MCHR1CA12CA1
SCHEMBL6649632 0.95 CA12 (0.46) PLA2G2CALDH1A1MCHR1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF WYETH (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF HSP90AB2P, HSP90AB1, HSP90AA1 PLA2G2C 620/4885ALDH1A1 2092/4885MCHR1 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.